NCT00938145Active, not recruiting
3 Tesla MRI in Patients With Bladder Cancer
Imaging of Bladder Cancer Using Clinical 3 Tesla MRI and EX-VIVO Ultra-High-Field MRI.
Source: ClinicalTrials.gov · Last updated 11 Apr 2025
Brief summary (registry, in English)
RATIONALE: New diagnostic procedures, such as 3 Tesla magnetic resonance imaging (MRI), may help find bladder cancer and learn the extent of disease. PURPOSE: This clinical trial is studying how well 3 Tesla MRI works in finding cancer in patients with bladder cancer.
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 98 (actual)
- First submitted
- 10 Jul 2009
- Start date
- 8 Jul 2009
- Primary completion date
- 31 Dec 2026
- Lead sponsor
- University of Cincinnati
- Diseases
- Bladder cancer
- NCT number
- NCT00938145
What you commit to
- Study type: Interventional
- Participants enrolled: 98
- From 8 Jul 2009 to the primary completion date, 31 Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- No allergy to contrast agents.
- Patient with significant renal insufficiency, i.e. an estimated glomerular filtration rate(eGRF) less than 30 mL/min/1.73m2.
- Any condition conflict based on the investigation's clinical judgment that would prevent the patient from completion all trial assessments and visits.
Other
- Not pregnant, planning to become pregnant during the study, or nursing.
- Inability or unwillingness to cooperate with requirements of this trial.
- Patients who exhibit noticeable anxiety and/or claustrophobia or who exhibit severe vertigo when they are moved into the MR.
- Patients with sickle cell anemia and other hemolytic anemia.
Who the study is looking for
- Known bladder cancer
- Scheduled for radical cystectomy and lymph node dissection.
- Able and willing to give valid written informed consent.
- No contraindications to the MRI(magnetic resonance imaging).
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Ohio State University Medical Center Coordinator of this site? Confirm its status | Columbus | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.